# Open Label, Healthy Volunteers, ADME Study With Single Oral Administration of [14C] AZD5069

> **NCT01332903** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 6 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C] AZD5069

## Key facts

- **NCT ID:** NCT01332903
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2015-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01332903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01332903, "Open Label, Healthy Volunteers, ADME Study With Single Oral Administration of [14C] AZD5069". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01332903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*